US Pharma MarketingExclusive: Inside the covert campaign to push out FDA Commissioner Marty Makary
Jilted biotechs coordinated a covert campaign with the Trump administration and Capitol Hill that helped push out FDA Commissioner Marty Makary. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for…
Biohaven CEO Vlad Coric finally had the attention of the FDA, and most importantly, Commissioner Marty Makary.
In late April, after the company’s spinocerebellar ataxia drug had been rejected last year, Coric had won a ...
Source: Endpoints News